Interestingly, the TERT promoter mutation always occurred in the setting of patients with IDH1/2 mutation [9, 10] and this mutation highly correlated with upregulated TERT mRNA expression and tumor grade in adult gliomas [11, 12]. Here, IDH1 is linked to central nervous system cancer.